L&K Biomed Ltd. (KOSDAQ:156100)

South Korea flag South Korea · Delayed Price · Currency is KRW
7,340.00
-220.00 (-2.91%)
At close: Apr 9, 2026
Market Cap170.09B +28.1%
Revenue (ttm)38.92B +7.8%
Net Income-16.30B
EPS-802.00
Shares Out22.35M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume196,098
Average Volume172,723
Open7,770.00
Previous Close7,560.00
Day's Range7,330.00 - 7,770.00
52-Week Range5,570.00 - 16,400.00
Beta0.92
RSI28.46
Earnings DateMay 14, 2026

About L&K Biomed

L&K Biomed Ltd., a medical company, manufactures and sells spinal implants in South Korea, the United States, Thailand, and internationally. The company offers spinal products comprising BlueEX-T, BluEX-TC, BluEX-A, BlueEX-L, and BluEX-ATP; BluEX-LT, an advanced lateral cage system for spinal lordosis restoration; PathLoc-TM, an expandable TLIF/PLIF lumbar cage system; AccelFix-XL, an expandable lateral lumbar cage system; AccelFix-XTP, an expandable lumbar cage system for anterior-to-psoas approach; and PathLoc-TA, an expandable ALIF anterior ... [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 2008
Employees 101
Stock Exchange KOSDAQ
Ticker Symbol 156100
Full Company Profile

Financial Performance

Financial Statements